More than one million older people in England will be invited to get vaccines for respiratory syncytial virus (RSV), with ...

RSV, respiratory syncytial virus, usually peaks in December and January while infecting the nose, throat and lungs, usually ...

During the COVID pandemic, RSV showed a slightly odd pattern: like flu, it basically disappeared in the 2020–2021 season, ...

Those most at risk from RSV include babies under 6 months old, young children who were born prematurely, and adults over 75-years-old ...

It spreads through inhalation or contact with the fluids from an infected person's coughs or sneezes. 2 While often linked to ...

Two new studies, one based on households in southeast Michigan and one involving hospitalized Japanese adults, compare ...

Despite the slightly warmer weather and longer periods of sunshine, we are still in the depths of cold and flu season, a ...

Nirsevimab is protective against RSV infections and coinfections, which suggests there is no replacement of RSV with other viruses post-nirsevimab administration.

Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children under two years old, resulting in significant morbidity and a heavy economic burden on healthcare ...

The NHS is urging around 1.3 million older people who have not yet had the respiratory syncytial virus vaccine to get jabbed, as health service chiefs warn it is “not just a winter illness”. Invites ...

More than 86,000 recorded cases of respiratory syncytial virus in 2024 were in children younger than four years old.

A nationwide surge in flu, COVID-19, RSV and norovirus infections is fueling concerns of a possible virus "quademic." Or is it just winter? The three respiratory viruses plus norovirus ...